BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32052612)

  • 21. Systemic application of photosensitizers in the chick chorioallantoic membrane (CAM) model: photodynamic response of CAM vessels and 5-aminolevulinic acid uptake kinetics by transplantable tumors.
    Hornung R; Hammer-Wilson MJ; Kimel S; Liaw LH; Tadir Y; Berns MW
    J Photochem Photobiol B; 1999 Mar; 49(1):41-9. PubMed ID: 10365445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mass Spectrometric Analysis of the Photobleaching of Protoporphyrin IX Used in Photodynamic Diagnosis and Therapy of Cancer.
    Ogbonna SJ; Hazama H; Awazu K
    Photochem Photobiol; 2021 Sep; 97(5):1089-1096. PubMed ID: 33687739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration.
    Chang SC; Buonaccorsi G; MacRobert AJ; Bown SG
    Lasers Surg Med; 1997; 20(3):254-64. PubMed ID: 9138254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of 5-aminolevulinic acid-based photodynamic therapy via reactive oxygen species in human cholangiocarcinoma cells.
    Kim CH; Chung CW; Choi KH; Yoo JJ; Kim DH; Jeong YI; Kang DH
    Int J Nanomedicine; 2011; 6():1357-63. PubMed ID: 21760730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simulations of measured photobleaching kinetics in human basal cell carcinomas suggest blood flow reductions during ALA-PDT.
    Wang KK; Cottrell WJ; Mitra S; Oseroff AR; Foster TH
    Lasers Surg Med; 2009 Nov; 41(9):686-96. PubMed ID: 19802891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
    Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
    Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring ALA-induced PpIX photodynamic therapy in the rat esophagus using fluorescence and reflectance spectroscopy.
    Kruijt B; de Bruijn HS; van der Ploeg-van den Heuvel A; de Bruin RW; Sterenborg HJ; Amelink A; Robinson DJ
    Photochem Photobiol; 2008; 84(6):1515-27. PubMed ID: 18557821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect.
    Robinson DJ; de Bruijn HS; van der Veen N; Stringer MR; Brown SB; Star WM
    Photochem Photobiol; 1998 Jan; 67(1):140-9. PubMed ID: 9477772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas.
    Cottrell WJ; Paquette AD; Keymel KR; Foster TH; Oseroff AR
    Clin Cancer Res; 2008 Jul; 14(14):4475-83. PubMed ID: 18628462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.
    Anayo L; Magnussen A; Perry A; Wood M; Curnow A
    Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of excimer delayed fluorescence by Protoporphyrin IX: A novel access to local chromophore concentration?
    Croizat G; Gregor A; Joniova J; Gerelli E; Wagnières G
    J Photochem Photobiol B; 2022 Apr; 229():112408. PubMed ID: 35294918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
    Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular Effects of Photodynamic Therapy with Curcumin in a Chorioallantoic Membrane Model.
    Buzzá HH; Fialho de Freitas LC; Moriyama LT; Teixeira Rosa RG; Bagnato VS; Kurachi C
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30832361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smartphone fluorescence imager for quantitative dosimetry of protoporphyrin-IX-based photodynamic therapy in skin.
    Ruiz AJ; LaRochelle EPM; Gunn JR; Hull SM; Hasan T; Chapman MS; Pogue BW
    J Biomed Opt; 2019 Dec; 25(6):1-13. PubMed ID: 31820594
    [No Abstract]   [Full Text] [Related]  

  • 35. Monte Carlo modeling of in vivo protoporphyrin IX fluorescence and singlet oxygen production during photodynamic therapy for patients presenting with superficial basal cell carcinomas.
    Valentine RM; Brown CT; Moseley H; Ibbotson S; Wood K
    J Biomed Opt; 2011 Apr; 16(4):048002. PubMed ID: 21529097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
    Choudry K; Brooke RC; Farrar W; Rhodes LE
    Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and pharmacological modification of resistance mechanisms to protoporphyrin-mediated photodynamic therapy in human cutaneous squamous cell carcinoma cell lines.
    Schary N; Novak B; Kämper L; Yousf A; Lübbert H
    Photodiagnosis Photodyn Ther; 2022 Sep; 39():103004. PubMed ID: 35811052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
    Mikolajewska P; Iani V; Juzeniene A; Moan J
    Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing the administrated light dose during 5-ALA-mediated photodynamic therapy: Murine 4T1 breast cancer model.
    Amiri H; Mokhtari-Dizaji M; Mozdarani H
    Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12925. PubMed ID: 37968826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protoporphyrin IX formation after topical application of methyl aminolaevulinate and BF-200 aminolaevulinic acid declines with age.
    Nissen CV; Philipsen PA; Wulf HC
    Br J Dermatol; 2015 Sep; 173(3):760-6. PubMed ID: 25997508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.